Beactica AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Beactica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013116
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction analysis, discovery of non-competitive ligands and allosteric sites among others. It uses SPR-based small molecule drug discovery platform for lead identification and optimization. The company works in partnership with Dong-A ST and other pharmaceutical and biotechnology companies. Beactica is headquartered in Uppsala, Sweden.

Beactica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Beactica AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Beactica Raises Funds through Venture Financing 10
Partnerships 11
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 11
Beactica Enters into Drug Discovery Agreement with Medivir 12
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 13
Beactica Enters Into Research Agreement With Janssen Research & Development 14
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 15
Beactica Enters Into An Agreement With Janssen 16
Licensing Agreements 17
Dong-A ST Enters into Licensing Agreement with Beactica 17
Beactica AB – Key Competitors 18
Beactica AB – Key Employees 19
Beactica AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Nov 06, 2017: Beactica Appoints Erik Wallden and Uli Hacksell to its Board of Directors 21
Other Significant Developments 22
Oct 12, 2016: Beactica Participates in EU Training Network on Fragment-Based Drug Discovery 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Beactica AB, Pharmaceuticals & Healthcare, Key Facts 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Beactica AB, Deals By Therapy Area, 2011 to YTD 2017 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Beactica Raises Funds through Venture Financing 10
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 11
Beactica Enters into Drug Discovery Agreement with Medivir 12
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 13
Beactica Enters Into Research Agreement With Janssen Research & Development 14
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 15
Beactica Enters Into An Agreement With Janssen 16
Dong-A ST Enters into Licensing Agreement with Beactica 17
Beactica AB, Key Competitors 18
Beactica AB, Key Employees 19
Beactica AB, Other Locations 20

★海外企業調査レポート[Beactica AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務分析
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Groupe Bruxelles Lambert SA:企業の戦略・SWOT・財務分析
    Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report Summary Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lycera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) a …
  • Macquarie Group Ltd:戦略・SWOT・企業財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Orlando Utilities Commission:電力:M&Aディール及び事業提携情報
    Summary Orlando Utilities Commission (OUC) is a municipally-owned public utility that provides water and electric services. The commission generates, transmits, and distributes electricity and water to residential and commercial customers. It also constructs, operates and maintains electric and wate …
  • Ecsponent Limited (ECS):企業の財務・戦略的SWOT分析
    Ecsponent Limited (ECS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • The Berkeley Group Holdings Plc:企業の戦略・SWOT・財務情報
    The Berkeley Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary The Berkeley Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Molnlycke Health Care AB-医療機器分野:企業M&A・提携分析
    Summary Molnlycke Health Care AB (Molnlycke) a subsidiary of Investor AB, is a medical device company. The company carries out the manufacturing and marketing of single-use surgical and wound care products. The company offers a range of surgical and wound care products; infection prevention solution …
  • Sysmex Corp (6869):医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • The Home Depot, Inc.:企業の戦略・SWOT・財務情報
    The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Texas Instruments Incorporated (TXN):電力:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • Schlumberger Ltd (SLB)-石油・ガス分野:企業M&A・提携分析
    Summary Schlumberger Limited (Schlumberger) is an oilfield services company that provides technology for reservoir characterization, drilling, production, and processing to the oil and gas industry. Schlumberger also supplies the industries with products and services, from exploration through produc …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Stentys SA (STNT):企業の財務・戦略的SWOT分析
    Summary Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include xposition S self-applying stent, mistent biodegradable sirolimus relea …
  • Nemus Bioscience Inc (NMUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆